User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The investigation of acute optic neuritis: a review and proposed protocol

  1. Hickman SJ, Dalton CM, Miller DH, Plant GT, Management of acute optic neuritis, 10.1016/s0140-6736(02)11919-2
  2. Fraser Clare L, Davagnanam Indran, Radon Mark, Plant Gordon T, The time course and phenotype of Uhthoff phenomenon following optic neuritis, 10.1177/1352458511431074
  3. Frohman Teresa C., Davis Scott L., Beh Shin, Greenberg Benjamin M., Remington Gina, Frohman Elliot M., Uhthoff's phenomena in MS—clinical features and pathophysiology, 10.1038/nrneurol.2013.98
  4. Hess K., Gresty M., Leech J., Clinical and theoretical aspects of head movement dependent oscillopsia (HMDO) : A review, 10.1007/bf00314530
  5. Serra Alessandro, Derwenskus Joy, Downey Deborah L., Leigh R. John, Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis, 10.1007/s00415-003-1038-8
  6. Sharpe J. A., Goldberg H. J., Lo A. W., Herishanu Y. O., Visual-vestibular interaction in multiple sclerosis, 10.1212/wnl.31.4_part_2.427
  7. Petzold Axel, Plant Gordon T., Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported, 10.1007/s00415-013-6957-4
  8. Wingerchuk D. M., Lennon V. A., Pittock S. J., Lucchinetti C. F., Weinshenker B. G., Revised diagnostic criteria for neuromyelitis optica, 10.1212/01.wnl.0000216139.44259.74
  9. Gabilondo Iñigo, Martínez-Lapiscina Elena H., Martínez-Heras Eloy, Fraga-Pumar Elena, Llufriu Sara, Ortiz Santiago, Bullich Santiago, Sepulveda Maria, Falcon Carles, Berenguer Joan, Saiz Albert, Sanchez-Dalmau Bernardo, Villoslada Pablo, Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis : Axonal Degeneration in MS, 10.1002/ana.24030
  10. Jenkins T., Hum. Brain Mapp., 31, 276 (2010)
  11. Masland Richard H., The Neuronal Organization of the Retina, 10.1016/j.neuron.2012.10.002
  12. Jonas J. B., Invest. Ophthalmol. Vis. Sci., 33, 2012 (1992)
  13. Hubel David, Wiesel Torsten, David Hubel and Torsten Wiesel, 10.1016/j.neuron.2012.07.002
  14. Gilbert Charles D., Li Wu, Top-down influences on visual processing, 10.1038/nrn3476
  15. Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker B G, Plant G T, Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis, 10.1136/jnnp.2008.146894
  16. Polman Chris H., Reingold Stephen C., Edan Gilles, Filippi Massimo, Hartung Hans-Peter, Kappos Ludwig, Lublin Fred D., Metz Luanne M., McFarland Henry F., O'Connor Paul W., Sandberg-Wollheim Magnhild, Thompson Alan J., Weinshenker Brian G., Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, 10.1002/ana.20703
  17. Lepore Frederick E., The Origin of Pain in Optic Neuritis : Determinants of Pain in 101 Eyes With Optic Neuritis, 10.1001/archneur.1991.00530190096021
  18. Petzold Axel, Pitz Eckhart, The Historical Origin of the Pulfrich Effect: A Serendipitous Astronomic Observation at the Border of the Milky Way, 10.1080/01658100802590829
  19. McGowan G., Ahmed T. Y., Heron G., Diaper C., The Pulfrich phenomenon; clumsiness and collisions which can be ameliorated, 10.1136/practneurol-2011-000013
  20. KAWASAKI AKI, MOORE PAULA, KARDON RANDY H., Long-term Fluctuation of Relative Afferent Pupillary Defect in Subjects With Normal Visual Function, 10.1016/s0002-9394(14)70385-x
  21. Leigh R. J., Serra A., Taking the temperature of MS with INO, 10.1212/01.wnl.0000304347.56133.b4
  22. Balcer L. J., Baier M. L., Cohen J. A., Kooijmans M. F., Sandrock A. W., Nano-Schiavi M. L., Pfohl D. C., Mills M., Bowen J., Ford C., Heidenreich F. R., Jacobs D. A., Markowitz C. E., Stuart W. H., Ying G.-S., Galetta S. L., Maguire M. G., Cutter G. R., Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite, 10.1212/01.wnl.0000094315.19931.90
  23. Rodriguez-Carmona Marisa, O’Neill-Biba Matilda, Barbur John L., Assessing the Severity of Color Vision Loss with Implications for Aviation and Other Occupational Environments, 10.3357/asem.3111.2012
  24. Frohman Elliot M., Dwyer Michael G., Frohman Teresa, Cox Jennifer L., Salter Amber, Greenberg Benjamin M., Hussein Sara, Conger Amy, Calabresi Peter, Balcer Laura J., Zivadinov Robert, Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: A pilot study, 10.1016/j.jns.2009.04.010
  25. Menke Marcel N., Dabov Simeon, Knecht Pascal, Sturm Veit, Reproducibility of Retinal Thickness Measurements in Healthy Subjects Using Spectralis Optical Coherence Tomography, 10.1016/j.ajo.2008.09.005
  26. Kisimbi John, Shalchi Zaid, Mahroo Omar A., Mhina Celina, Sanyiwa Anna J., Mabey Denise, Mohamed Moin, Plant Gordon T., Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy, 10.1093/brain/awt221
  27. Abegg Mathias, Dysli Muriel, Wolf Sebastian, Kowal Jens, Dufour Pascal, Zinkernagel Martin, Microcystic Macular Edema, 10.1016/j.ophtha.2013.08.045
  28. Petzold Axel, de Boer Johannes F, Schippling Sven, Vermersch Patrik, Kardon Randy, Green Ari, Calabresi Peter A, Polman Chris, Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis, 10.1016/s1474-4422(10)70168-x
  29. Balk L. J., Twisk J. W. R., Steenwijk M. D., Daams M., Tewarie P., Killestein J., Uitdehaag B. M. J., Polman C. H., Petzold A., A dam for retrograde axonal degeneration in multiple sclerosis?, 10.1136/jnnp-2013-306902
  30. Pfueller Caspar F., Brandt Alexander U., Schubert Florian, Bock Markus, Walaszek Bernadeta, Waiczies Helmar, Schwenteck Thomas, Dörr Jan, Bellmann-Strobl Judith, Mohr Christian, Weinges-Evers Nicholetta, Ittermann Bernd, Wuerfel Jens T., Paul Friedemann, Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis, 10.1371/journal.pone.0018019
  31. Costello Fiona, Coupland Stuart, Hodge William, Lorello Gianni R., Koroluk Jeannie, Pan Y. Irene, Freedman Mark S., Zackon David H., Kardon Randy H., Quantifying axonal loss after optic neuritis with optical coherence tomography, 10.1002/ana.20851
  32. Toosy Ahmed T, Mason Deborah F, Miller David H, Optic neuritis, 10.1016/s1474-4422(13)70259-x
  33. Brandt Alexander U., Zimmermann Hanna, Kaufhold Falko, Promesberger Julia, Schippling Sven, Finis David, Aktas Orhan, Geis Christian, Ringelstein Marius, Ringelstein E. Bernd, Hartung Hans-Peter, Paul Friedemann, Kleffner Ilka, Dörr Jan, Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS, 10.1371/journal.pone.0038741
  34. Nagia Lina, Eggenberger Eric, Differentiating retinal from optic nerve syndromes : , 10.1097/icu.0000000000000004
  35. Bichuetti Denis B., de Camargo André S., Falcão Alessandra B., Gonçalves Fabiana F., Tavares Ivan M., de Oliveira Enedina M.L., The Retinal Nerve Fiber Layer of Patients With Neuromyelitis Optica and Chronic Relapsing Optic Neuritis is More Severely Damaged than Patients With Multiple Sclerosis : , 10.1097/wno.0b013e31829f39f1
  36. Bouyon M, Collongues N, Zéphir H, Ballonzoli L, Jeanjean L, Lebrun C, Chanson JB, Blanc F, Fleury M, Outteryck O, Defoort S, Labauge P, Vermersch P, Speeg C, De Seze J, Longitudinal follow-up of vision in a neuromyelitis optica cohort, 10.1177/1352458513476562
  37. Fernandes Danilo B., Raza Ali S., Nogueira Rafael G.F., Wang Diane, Callegaro Dagoberto, Hood Donald C., Monteiro Mario L.R., Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography, 10.1016/j.ophtha.2012.07.066
  38. Kaufhold Falko, Zimmermann Hanna, Schneider Elisa, Ruprecht Klemens, Paul Friedemann, Oberwahrenbrock Timm, Brandt Alexander U., Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis, 10.1371/journal.pone.0071145
  39. Nakamura Masahiko, Nakazawa Toru, Doi Hiroshi, Hariya Takehiro, Omodaka Kazuko, Misu Tatsuro, Takahashi Toshiyuki, Fujihara Kazuo, Nishida Kohji, Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica, 10.1007/s00417-010-1344-7
  40. Gelfand J. M., Nolan R., Schwartz D. M., Graves J., Green A. J., Microcystic macular oedema in multiple sclerosis is associated with disease severity, 10.1093/brain/aws098
  41. Schneider Elisa, Zimmermann Hanna, Oberwahrenbrock Timm, Kaufhold Falko, Kadas Ella Maria, Petzold Axel, Bilger Frieder, Borisow Nadja, Jarius Sven, Wildemann Brigitte, Ruprecht Klemens, Brandt Alexander U., Paul Friedemann, Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis, 10.1371/journal.pone.0066151
  42. Balk L. J., Killestein J., Polman C. H., Uitdehaag B. M. J., Petzold A., Microcystic macular oedema confirmed, but not specific for multiple sclerosis, 10.1093/brain/aws216
  43. Burggraaff Marloes C., Trieu Jennifer, de Vries-Knoppert Willemien A. E. J., Balk Lisanne, Petzold Axel, The Clinical Spectrum of Microcystic Macular Edema, 10.1167/iovs.13-12912
  44. Gelfand Jeffrey M., Cree Bruce A., Nolan Rachel, Arnow Sam, Green Ari J., Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica, 10.1001/jamaneurol.2013.1832
  45. Sotirchos E. S., Saidha S., Byraiah G., Mealy M. A., Ibrahim M. A., Sepah Y. J., Newsome S. D., Ratchford J. N., Frohman E. M., Balcer L. J., Crainiceanu C. M., Nguyen Q. D., Levy M., Calabresi P. A., In vivo identification of morphologic retinal abnormalities in neuromyelitis optica, 10.1212/wnl.0b013e31828c2f7a
  46. Tewarie Prejaas, Balk Lisanne, Costello Fiona, Green Ari, Martin Roland, Schippling Sven, Petzold Axel, The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment, 10.1371/journal.pone.0034823
  47. Stabler Sally P., Vitamin B12 Deficiency, 10.1056/nejmcp1113996
  48. Jarius S., Paul F., Ruprecht K., Wildemann B., Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders, 10.1007/s00415-012-6677-1
  49. Agmon-Levin Nancy, Damoiseaux Jan, Kallenberg Cees, Sack Ulrich, Witte Torsten, Herold Manfred, Bossuyt Xavier, Musset Lucille, Cervera Ricard, Plaza-Lopez Aresio, Dias Carlos, Sousa Maria José, Radice Antonella, Eriksson Catharina, Hultgren Olof, Viander Markku, Khamashta Munther, Regenass Stephan, Andrade Luis Eduardo Coelho, Wiik Allan, Tincani Angela, Rönnelid Johan, Bloch Donald B, Fritzler Marvin J, Chan Edward K L, Garcia-De La Torre I, Konstantinov Konstantin N, Lahita Robert, Wilson Merlin, Vainio Olli, Fabien Nicole, Sinico Renato Alberto, Meroni Pierluigi, Shoenfeld Yehuda, International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies, 10.1136/annrheumdis-2013-203863
  50. Jarius Sven, Ruprecht Klemens, Wildemann Brigitte, Kuempfel Tania, Ringelstein Marius, Geis Christian, Kleiter Ingo, Kleinschnitz Christoph, Berthele Achim, Brettschneider Johannes, Hellwig Kerstin, Hemmer Bernhard, Linker Ralf A, Lauda Florian, Mayer Christoph A, Tumani Hayrettin, Melms Arthur, Trebst Corinna, Stangel Martin, Marziniak Martin, Hoffmann Frank, Schippling Sven, Faiss Jürgen H, Neuhaus Oliver, Ettrich Barbara, Zentner Christian, Guthke Kersten, Hofstadt-van Oy Ulrich, Reuss Reinhard, Pellkofer Hannah, Ziemann Ulf, Kern Peter, Wandinger Klaus P, Then Bergh Florian, Boettcher Tobias, Langel Stefan, Liebetrau Martin, Rommer Paulus S, Niehaus Sabine, Münch Christoph, Winkelmann Alexander, Zettl U Uwe K, Metz Imke, Veauthier Christian, Sieb Jörn P, Wilke Christian, Hartung Hans P, Aktas Orhan, Paul Friedemann, Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients, 10.1186/1742-2094-9-14
  51. Myers T D, Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease, 10.1136/bjo.2003.028472
  52. Biotti Damien, Boucher Sophie, Ong Elodie, Tilikete Caroline, Vighetto Alain, Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome, 10.1007/s00415-013-7094-9
  53. Fujihara K., Leite M. I., Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges, 10.1212/wnl.0b013e318296ea22
  54. Jarius Sven, Wildemann Brigitte, Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature : Aquaporin-4 Antibodies as Diagnostic Marker of Neuromyelitis Optica, 10.1111/bpa.12084
  55. Waters P. J., McKeon A., Leite M. I., Rajasekharan S., Lennon V. A., Villalobos A., Palace J., Mandrekar J. N., Vincent A., Bar-Or A., Pittock S. J., Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays, 10.1212/wnl.0b013e318248dec1
  56. Jarius Sven, Frederikson Jette, Waters Patrick, Paul Friedemann, Akman-Demir Gulsen, Marignier Romain, Franciotta Diego, Ruprecht Klemens, Kuenz Bettina, Rommer Paulus, Kristoferitsch Wolfgang, Wildemann Brigitte, Vincent Angela, Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis, 10.1016/j.jns.2010.07.011
  57. Matiello M., Lennon V. A., Jacob A., Pittock S. J., Lucchinetti C. F., Wingerchuk D. M., Weinshenker B. G., NMO-IgG predicts the outcome of recurrent optic neuritis, 10.1212/01.wnl.0000303817.82134.da
  58. Kitley Joanna, Waters Patrick, Woodhall Mark, Leite M. Isabel, Murchison Andrew, George Jithin, Küker Wilhelm, Chandratre Saleel, Vincent Angela, Palace Jacqueline, Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies : A Comparative Study, 10.1001/jamaneurol.2013.5857
  59. Sato D. K., Callegaro D., Lana-Peixoto M. A., Waters P. J., Jorge F. M. d. H., Takahashi T., Nakashima I., Apostolos-Pereira S. L., Talim N., Simm R. F., Lino A. M. M., Misu T., Leite M. I., Aoki M., Fujihara K., Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders, 10.1212/wnl.0000000000000101
  60. Stangel Martin, Fredrikson Sten, Meinl Edgar, Petzold Axel, Stüve Olaf, Tumani Hayrettin, The utility of cerebrospinal fluid analysis in patients with multiple sclerosis, 10.1038/nrneurol.2013.41
  61. Petzold Axel, Intrathecal oligoclonal IgG synthesis in multiple sclerosis, 10.1016/j.jneuroim.2013.06.014
  62. Jarius S., Paul F., Franciotta D., Ruprecht K., Ringelstein M., Bergamaschi R., Rommer P., Kleiter I., Stich O., Reuss R., Rauer S., Zettl U.K., Wandinger K.P., Melms A., Aktas O., Kristoferitsch W., Wildemann B., Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures, 10.1016/j.jns.2011.03.038
  63. Nakamura M., Nakashima I., Sato S., Miyazawa I., Fujihara K., Itoyama Y., Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands, 10.1177/13524585070130030201
  64. Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y, Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker, 10.1136/jnnp.2008.150698
  65. Petzold A., Marignier R., Verbeek M. M., Confavreux C., Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases, 10.1136/jnnp.2009.196550
  66. Takano R., Misu T., Takahashi T., Sato S., Fujihara K., Itoyama Y., Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study, 10.1212/wnl.0b013e3181e2414b
  67. Uzawa Akiyuki, Mori Masahiro, Sawai Setsu, Masuda Saeko, Muto Mayumi, Uchida Tomohiko, Ito Shoichi, Nomura Fumio, Kuwabara Satoshi, Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks, 10.1016/j.cca.2013.03.020
  68. Dörr Jan, Döring Andrea, Paul Friedemann, Can we prevent or treat multiple sclerosis by individualised vitamin D supply?, 10.1186/1878-5085-4-4
  69. von Geldern Gloria, Mowry Ellen M., The influence of nutritional factors on the prognosis of multiple sclerosis, 10.1038/nrneurol.2012.194
  70. Petzold A, Axonal degeneration and inflammation in acute optic neuritis, 10.1136/jnnp.2003.017236
  71. Petzold Axel, Plant Gordon T., The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic Neuropathies, 10.1155/2012/217802
  72. Talla Venu, Yang Cui, Shaw Gerry, Porciatti Vittorio, Koilkonda Rajeshwari D., Guy John, Noninvasive Assessments of Optic Nerve Neurodegeneration in Transgenic Mice With Isolated Optic Neuritis, 10.1167/iovs.13-11899
  73. Barkhof Frederik, Calabresi Peter A., Miller David H., Reingold Stephen C., Imaging outcomes for neuroprotection and repair in multiple sclerosis trials, 10.1038/nrneurol.2009.41
  74. Kolappan M., Henderson A. P. D., Jenkins T. M., Wheeler-Kingshott C. A. M., Plant G. T., Thompson A. J., Miller D. H., Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis, 10.1007/s00415-009-0123-z
  75. Miller D. H., Newton M. R., van der Poel J. C., du Boulay E. P. G. H., Halliday A. M., Kendall B. E., Johnson G., MacManus D. G., Moseley I. F., McDonald W. I., Magnetic resonance imaging of the optic nerve in optic neuritis, 10.1212/wnl.38.2.175
  76. Hickman S.J., Toosy A.T., Miszkiel K.A., Jones S.J., Altmann D.R., MacManus D.G., Plant G.T., Thompson A.J., Miller D.H., Visual recovery following acute optic neuritis : A clinical, electrophysiological and magnetic resonance imaging study, 10.1007/s00415-004-0477-1
  77. Kupersmith Mark J., Alban Therese, Zeiffer Barbara, Lefton Daniel, Contrast‐enhanced MRI in acute optic neuritis: relationship to visual performance, 10.1093/brain/awf087
  78. Khanna Sangeeta, Sharma Aseem, Huecker Julie, Gordon Mae, Naismith Robert T., Van Stavern Gregory P., Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis : , 10.1097/wno.0b013e318254c62d
  79. Storoni Mithu, Davagnanam Indran, Radon Mark, Siddiqui Ata, Plant Gordon T., Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis : A Novel Magnetic Resonance Imaging Scoring System, 10.1097/wno.0b013e318283c3ed
  80. Wattjes Mike P., Barkhof Frederik, High field MRI in the diagnosis of multiple sclerosis: high field–high yield?, 10.1007/s00234-009-0512-0
  81. Wattjes M. P., Harzheim M., Lutterbey G. G., Hojati F., Simon B., Schmidt S., Schild H. H., Barkhof F., Does high field MRI allow an earlier diagnosis of multiple sclerosis?, 10.1007/s00415-008-0861-3
  82. Karim Shaheen, Clark Robert A., Poukens Vadims, Demer Joseph L., Demonstration of Systematic Variation in Human Intraorbital Optic Nerve Size by Quantitative Magnetic Resonance Imaging and Histology, 10.1167/iovs.03-1246
  83. Trip S. Anand, Schlottmann Patricio G., Jones Stephen J., Li Wai-Yung, Garway-Heath David F., Thompson Alan J., Plant Gordon T., Miller David H., Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy, 10.1016/j.neuroimage.2005.11.051
  84. Trip SA, Schlottmann PG, Jones SJ, Li W-Y., Garway-Heath DF, Thompson AJ, Plant GT, Miller DH, Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis, 10.1177/1352458507076952
  85. Trip S. Anand, Wheeler-Kingshott Claudia, Jones Stephen J., Li Wai-Yung, Barker Gareth J., Thompson Alan J., Plant Gordon T., Miller David H., Optic nerve diffusion tensor imaging in optic neuritis, 10.1016/j.neuroimage.2005.09.024
  86. Glisson Christopher C., Galetta Steven L., Nonconventional Optic Nerve Imaging in Multiple Sclerosis, 10.1016/j.nic.2008.09.003
  87. Yiannakas Marios C., Toosy Ahmed T., Raftopoulos Rhian E., Kapoor Raj, Miller David H., Wheeler-Kingshott Claudia A. M., MRI Acquisition and Analysis Protocol for In Vivo Intraorbital Optic Nerve Segmentation at 3T, 10.1167/iovs.13-12357
  88. Holder Graham E, Gale Richard P, Acheson James F, Robson Anthony G, Electrodiagnostic assessment in optic nerve disease : , 10.1097/wco.0b013e328320264c
  89. Holder Graham E, Pattern Electroretinography (PERG) and an Integrated Approach to Visual Pathway Diagnosis, 10.1016/s1350-9462(00)00030-6
  90. Odom J. Vernon, Bach Michael, Brigell Mitchell, Holder Graham E., McCulloch Daphne L., Tormene Alma Patrizia, Vaegan, ISCEV standard for clinical visual evoked potentials (2009 update), 10.1007/s10633-009-9195-4
  91. Nightingale S, Mitchell K W, Howe J W, Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects., 10.1136/jnnp.49.11.1280
  92. Boylu E., Electromyogr. Clin. Neurophysiol., 50, 303 (2010)
  93. Fraser Clare L., Holder Graham E., Electroretinogram findings in unilateral optic neuritis, 10.1007/s10633-011-9294-x
  94. Fraser Clare, Klistorner Alexander, Graham Stuart, Garrick Raymond, Billson Francis, Grigg John, Multifocal Visual Evoked Potential Latency Analysis : Predicting Progression to Multiple Sclerosis, 10.1001/archneur.63.6.847
  95. Holder Graham E., The incidence of abnormal pattern electroretinography in optic nerve demyelination, 10.1016/0013-4694(91)90014-u
  96. Rodriguez-Mena Diego, Almarcegui Carmen, Dolz Isabel, Herrero Raquel, Bambo Maria P., Fernandez Javier, Pablo Luis E., Garcia-Martin Elena, Electropysiologic Evaluation of the Visual Pathway in Patients With Multiple Sclerosis : , 10.1097/wnp.0b013e31829d75f7
  97. Frohman T. C., Beh S. C., Saidha S., Schnurman Z., Conger D., Conger A., Ratchford J. N., Lopez C., Galetta S. L., Calabresi P. A., Balcer L. J., Green A. J., Frohman E. M., Optic nerve head component responses of the multifocal electroretinogram in MS, 10.1212/wnl.0b013e31829e6faa
  98. Gerling J., Meyer J�rg Heinrich, Kommerell Guntram, Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features, 10.1007/s004170050062
  99. Keltner John L., Visual Field Profile of Optic Neuritis : A Final Follow-up Report From the Optic Neuritis Treatment Trial From Baseline Through 15 Years, 10.1001/archophthalmol.2010.16
  100. Petzold Axel, Islam Niaz, Hu Han-Hwa, Plant Gordon T., Embolic and Nonembolic Transient Monocular Visual Field Loss: A Clinicopathologic Review, 10.1016/j.survophthal.2012.02.002
  101. Purvin Valerie, Optic Perineuritis : Clinical and Radiographic Features, 10.1001/archopht.119.9.1299
  102. Petzold A., Plant G.T., Failure to detect bitemporal field defects due to chiasmal compression on a screening perimetry protocol, 10.1076/noph.24.2.357.7156
  103. Schiefer Ulrich, Pascual John P., Edmunds Beth, Feudner Elisabeth, Hoffmann Esther M., Johnson Chris A., Lagre`ze Wolf A., Pfeiffer Norbert, Sample Pamela A., Staubach Flemming, Weleber Richard G., Vonthein Reinhard, Krapp Elke, Paetzold Jens, Comparison of the New Perimetric GATE Strategy with Conventional Full-Threshold and SITA Standard Strategies, 10.1167/iovs.08-2229
  104. Author Index Vol. 55, 2000, 10.1159/000006670
  105. Scott Jennifer A, Egan Robert A, Prevalence of organic Neuro-ophthalmologic disease in patients with functional visual loss, 10.1016/s0002-9394(02)02254-7
  106. Trick Gary L., Trick Linda R., Morris Patricia, Wolf Mitchell, Visual field loss in senile dementia of the Alzheimer's type : , 10.1212/wnl.45.1.68
  107. Kutzko K. E., Invest. Ophthalmol. Vis. Sci., 41, 2006 (2000)
  108. Automated Perimetry, 10.1016/s0161-6420(96)30554-x
  109. Kerrigan-Baumrind L. A., Invest. Ophthalmol. Vis. Sci., 41, 741 (2000)
  110. Mikelberg Frederick S., Yidegiligne Haile M., Schulzer Michael, Optic Nerve Axon Count and won Diameter in Patients with Ocular Hypertension and Normal Visual Fields, 10.1016/s0161-6420(95)31019-6
  111. Javitt Jonathan C., A Modified Slit Lamp for Examination of Wheelchair-Bound Patients, 10.1001/archopht.1989.01070010463046
  112. Bhardwaj Namita, Perez Javier, Peden Marc, Optic Neuropathy from Cobalt Toxicity in a Patient who Ingested Cattle Magnets, 10.3109/01658107.2010.518334
  113. Wakefield Denis, Di Girolamo Nick, Thurau Stephan, Wildner Gerhild, McCluskey Peter, Scleritis: Immunopathogenesis and molecular basis for therapy, 10.1016/j.preteyeres.2013.02.004
  114. Coppens S., Petzold A., de Graaf P., de Vries-Knoppert W. A. E. J., Recurrent Optic Perineuritis after Intranasal Cocaine Abuse, 10.3109/01658107.2013.874450
Bibliographic reference Petzold, Axel ; Wattjes, Mike P ; Costello, Fiona ; Flores-Rivera, Jose ; Fraser, Clare L ; et. al. The investigation of acute optic neuritis: a review and proposed protocol. In: Nature Reviews Neurology, Vol. 10, no.8, p. 447-458 (2014)
Permanent URL http://hdl.handle.net/2078.1/153418